Local ablative radiotherapy on oligo-progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer patients: A longer cohort.
Florence Siu Ting MokMacy TongHerbert H LoongTony S K MokPublished in: Asia-Pacific journal of clinical oncology (2022)
LAR is a noninvasive and effective modality in treatment of oligo-progressive diseases for patients with EGFR mutations positive NSCLC while on EGFR-TKIs.
Keyphrases
- epidermal growth factor receptor
- advanced non small cell lung cancer
- tyrosine kinase
- small cell lung cancer
- early stage
- multiple sclerosis
- single cell
- radiation induced
- locally advanced
- radiation therapy
- mesenchymal stem cells
- bone marrow
- stem cells
- combination therapy
- chronic myeloid leukemia
- brain metastases
- replacement therapy
- rectal cancer
- smoking cessation